New answer by Medical Oncologist at Associate Clinical Professor, Division of Lymphoma, Department of Hematology & Hematopoietic Cell Transplantation (November 14, 2021)
While p53 mutations are known to impact clinical outcome after administration of cytotoxic chemotherapy in frontline MCL (Eskelund et al., PMID 29794145, Elhassadi E et al. Pr...